Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Revolutionising The Diagnosis Of Serious Disease
Revolutionary ultrasonic nanotechnology that could allow scientists to see inside a patient"s individual cells to help diagnose serious illnesses is being developed by researchers at The University of Nottingham.

Echo Therapeutics To Present At Prestigious 'Innovations In Diabetes' Conference
Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system, announced that Patrick T. Mooney, M.D., Chairman and Chief Executive Officer, will present at the "Innovations in Diabetes" Conference on, Tuesday, July 14, 2009 at 5:30 pm ET. The presentation will occur live and will be held at The Pier V Hotel at the Inner Harbor in Baltimore.
News of the day
Head Of Urologic Oncology At The Cancer Institute Of New Jersey Marks 500th Robotic Prostatectomy
Marking a unique milestone in prostate cancer surgery, the director of urologic oncology at The Cancer Institute of New Jersey (CINJ) has completed his 500th robotic prostatectomy at Robert Wood Johnson University Hospital (RWJUH), the Flagship Hospital of CINJ, which is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
Diagnostics

Darkness Linked To 'Brain Drain' In Depressed People

A lack of sunlight is associated with reduced cognitive function among depressed people. Researchers writing in BioMed Central"s open access journal Environmental Health used weather data from NASA satellites to measure sunlight exposure across the United States and linked this information to the prevalence of cognitive impairment in depressed people. Shia Kent, from the University of Alabama at Birmingham, led a team of US researchers who used cross-sectional data from 14,474 people in the NIH-NINDS-funded REGARDS study, a longitudinal study investigating stroke incidence and risk factors, to study associations between depression, cognitive function and sunlight. He said, "We found that among participants with depression, low exposure to sunlight was associated with a significantly higher predicted probability of cognitive impairment. This relationship remained significant after adjustment for season. This new finding that weather may not only affect mood, but also cognition, has significant implications for the treatment of depression, particularly seasonal affective disorder". Kent and his colleagues speculate that the physiological mechanisms that give rise to seasonal depression may also be involved in sunlight"s effect on cognitive function in the context of depressive symptoms. Cognitive function was assessed by measurement of short-term recall and temporal orientation. As well as regulating the hormones serotonin and melatonin, light has been shown to also affect brain blood flow, which has in turn been linked with cognitive functions. The researchers write, "Discovering the environment"s impact on cognitive functioning within the context of seasonal disorders may lead not only to better understanding of the disorders, but also to the development of targeted interventions to enhance everyday functioning and quality of life". Notes: Effect of sunlight exposure on cognitive function among depressed and non-depressed participants: a REGARDS cross-sectional study Shia T Kent, Leslie A McClure, William L Crosson, Donna K Arnett, Virginia G Wadley and Nalini Sathiakumar Environmental Health (in press) http://www.ehjournal.net/ Graeme Baldwin BioMed Central


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009